Search - tctmd.com

Displaying 41 - 60 of 85

Sort: Relevancy | Date

Presentation TCT 2018

Percutaneous PFO Closure: Finally Arrived?

Presenter: Jeroen J. Bax, Stephan Windecker, Lars Sondergaard

September 21, 2018

Presentation TCT 2018

How to Select Patients for Tricuspid Valve Repair

Presenter: Jeroen J. Bax, Stephan Windecker, Jörg Hausleiter

September 21, 2018

Presentation TCT 2018

The Future of Transcatheter Mitral Valve Intervention: Repair or Replace?

Presenter: Jeroen J. Bax, Stephan Windecker, Georg Nickenig

September 21, 2018

Presentation TCT 2018

Antithrombotic Therapy in Patients Undergoing TAVR

Presenter: Jeroen J. Bax, Stephan Windecker

September 21, 2018

Presentation TCT 2018

TAVR: New Indications and Unmet Needs

Presenter: Jeroen J. Bax, Stephan Windecker, Thomas Pilgrim

September 21, 2018

Presentation The Structural Heart Disease Summit 2018

Other Transcatheter TR Device Therapies Coaptation Spacers and Valve Replacement - Should Be Added to the Armamentarium

Presenter: Susheel K. Kodali

June 21, 2018

Presentation

Does Tricuspid Leaflet Grasping Make Sense As a Primary or Adjunctive TR Therapy?

Presenter: Georg Nickenig

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Does Tricuspid Leaflet Grasping Make Sense As a Primary or Adjunctive TR Therapy?

Presenter: Georg Nickenig

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

One-stop Shopping: Once TMVR Is Refined, Clearly the Preferred Therapy for Most MR Patients

Presenter: Martin B. Leon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Leaflet Chordal Suspension for Primary MR Will Importantly Augment the Surgical/Interventional Toolbox

Presenter: David H. Adams

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Transcatheter Mitral Annuloplasty Devices Will Be the "Centerpiece" in the Future

Presenter: Steven F. Bolling

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cant Beat Safety and Simplicity: Transcatheter Leaflet Approximation Technologies Will Continue to Dominate

Presenter: Ted Feldman

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NO: The Data Are Weak and the Costs Are Prohibitive!

Presenter: John K. Forrest

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

YES: Review of ALL the Data and Common Sense Tell the Story!

Presenter: Axel Linke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cedars-Sinai Medical Center (USA)

Presenter: Tarun Chakravarty

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Erasmus University (The Netherlands)

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Ulm University (Germany)

Presenter: Julia Seeger

June 21, 2018

Presentation TCT 2017

Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis!

Presenter: Gilles Dreyfus, Sanjay Kaul, Alfredo Trento

November 01, 2017

Presentation TCT 2017

Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis!

Presenter: Gilles Dreyfus, Sanjay Kaul, John G. Webb

November 01, 2017

Presentation TCT 2017

Flash Debate: Surveillance and Prophylactic Treatment of Asymptomatic TAVR Thrombosis Is Not Currently Warranted!

Presenter: Gilles Dreyfus, Sanjay Kaul, Hendrik Treede

November 01, 2017

Advertisement

Percutaneous PFO Closure: Finally Arrived?

How to Select Patients for Tricuspid Valve Repair

The Future of Transcatheter Mitral Valve Intervention: Repair or Replace?

Antithrombotic Therapy in Patients Undergoing TAVR

TAVR: New Indications and Unmet Needs

Other Transcatheter TR Device Therapies Coaptation Spacers and Valve Replacement - Should Be Added to the Armamentarium

Does Tricuspid Leaflet Grasping Make Sense As a Primary or Adjunctive TR Therapy?

Does Tricuspid Leaflet Grasping Make Sense As a Primary or Adjunctive TR Therapy?

One-stop Shopping: Once TMVR Is Refined, Clearly the Preferred Therapy for Most MR Patients

Leaflet Chordal Suspension for Primary MR Will Importantly Augment the Surgical/Interventional Toolbox

Transcatheter Mitral Annuloplasty Devices Will Be the "Centerpiece" in the Future

Cant Beat Safety and Simplicity: Transcatheter Leaflet Approximation Technologies Will Continue to Dominate

NO: The Data Are Weak and the Costs Are Prohibitive!

YES: Review of ALL the Data and Common Sense Tell the Story!

Cedars-Sinai Medical Center (USA)

Erasmus University (The Netherlands)

Ulm University (Germany)

Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis!

Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis!

Flash Debate: Surveillance and Prophylactic Treatment of Asymptomatic TAVR Thrombosis Is Not Currently Warranted!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content